A further 3 genes (RASSF5, MKK3 and LRIG1) were expressed at significantly lower levels in CLL patients with down-regulated MIR-15a/16-1 expression (Figure 3). This evidence concerns the gene MAP2K3 and B-cell chronic lymphocytic leukemia.